Bacteriocin ASP-1

General Information


DRACP ID  DRACP00784

Peptide Name   Bacteriocin ASP-1

Sequence  FTVAXFI

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacillus subtilis URID 12.1

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma IC50=192µg/ml MTS assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=280µg/ml MTS assay 24h 1

Hemolytic Activity  Human erythrocytes: <5% Hemolysis=128µg/ml; 30% Hemolysis=256µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  LCB: X(5)<--->Ile7

N-terminal Modification  Acetylation

C-terminal Modification  Free

Other Modification  X=dehydrobutyrine

Chiral  L



Physicochemical Information


Formula  C36H50N6O7

Absent amino acids  CDEGHKLMNPQRSWY

Common amino acids  F

Mass  89603

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  5

Net charge  0

Boman Index  1416

Hydrophobicity  220

Aliphatic Index  111.43

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28887200

Title  Purification and characterization of a novel anti-staphylococcal peptide (ASP-1) from bacillus sp. URID 12.1

Doi 10.1016/j.ijantimicag.2017.08.030

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.